CD19 and acute lymphoblastic leukemia: The shRNA-IL6-modified CD19-redirected CAR-Ts (ssCAR-T-19) were delivered to a B-ALL patient with skin and testicle extramedullary relapse enrolled in a clinical trial (NCT03919240) (70).